The slip
PARKINSON RECEIPTno. 8606
24 Oct 2026, 11:44 UTCdopamine neurons, braak
predictionTYK2 in dopamine neurons tracks Braak Lewy-body stage
registered6903b01c447d9517
discovery-0.27 p=0.489 n=9
replication-0.36 p=0.347 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.27, p 0.489)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTb4e0cd2894e3b8fd63886f27…
follows 389e206329a0…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8606: TYK2 in dopamine neurons, braak
- power
- full sample -0.31 (p 0.218, n 18), 95% CI -0.68 to +0.19. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.40 (p 0.101, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.36 (p 0.137, n 18). could be the mix.
- skeptic
- leave-one-out range -0.47 to -0.24, sign flips 0; without severely affected donors -0.31 (p 0.218, n 18). fragile.
- cell type
- strongest in OPCs: -0.71 (p 9.6e-4, n 18) vs -0.31 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TYK2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TYK2 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.05 p 0.859 (needs p < 2.5e-4)